Efficient and Sustainable Treatment of Tannery Wastewater by a Sequential Electrocoagulation-UV Photolytic Process

TL;DR

This study demonstrates that sequential electrocoagulation and UV photolysis effectively reduce pollutants in tannery wastewater, achieving over 94% COD removal and lowering toxicity, with energy consumption suitable for scaling up.

Contribution

It introduces a combined electrocoagulation-UV process as an efficient, sustainable method for tannery wastewater treatment, outperforming individual treatments.

Findings

94.1% COD reduction with combined treatment

Final COD below regulatory limit of 1000 mg/L

Reduced phytotoxicity in treated water

Abstract

Tannery wastewater contains large amounts of pollutants that, if directly discharged into ecosystems, can generate an environmental hazard. The present investigation has focused the attention to the remediation of wastewater originated from tanned leather in Tunisia. The analysis revealed wastewater with a high level of chemical oxygen demand (COD) of 7376 mgO2/L. The performance in reduction of COD, via electrocoagulation (EC) or UV photolysis or, finally, operating electrocoagulation and photolysis in sequence was examined. The effect of voltage and reaction time on COD reduction, as well as the phytotoxicity were determined. Treated effluents were analysed by UV spectroscopy, extracting the organic components with solvents differing in polarity. A sequential EC and UV treatment of the tannery wastewater has been proven effective in the reduction of COD. These treatments combined afforded 94.1 % of COD reduction, whereas the single EC and UV treatments afforded respectively 85.7 and 55.9 %. The final COD value of 428.7 mg/L was found largely below the limit of 1000 mg/L for admission of wastewater in public sewerage network. Germination tests of Hordeum Vulgare seeds indicated reduced toxicity for the remediated water. Energy consumptions of 33.33 kWh/m3 and 314.28 kWh/m3 were determined for the EC process and for the same followed by UV treatment. Both those technologies are yet available and ready for scale-up.